217 related articles for article (PubMed ID: 37308506)
1. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Salgado L; Carvalho L; Pereira D; Medeiros R
J Thromb Thrombolysis; 2024 Apr; ():. PubMed ID: 38643313
[TBL] [Abstract][Full Text] [Related]
3. Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.
Tavares V; Pinto R; Assis J; Coelho S; Brandão M; Alves S; Pereira D; Medeiros R
Pharmacogenomics J; 2021 Apr; 21(2):222-232. PubMed ID: 33161412
[TBL] [Abstract][Full Text] [Related]
4. Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.
Almasi M; Sevcikova S; Slaby O; Kaisarova P; Maisnar V; Penka M; Pika T; Pour L; Radocha J; Scudla V; Svachova H; Hajek R
Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):414-20. PubMed ID: 21859556
[TBL] [Abstract][Full Text] [Related]
5. Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels.
Khorana AA; Kuderer NM; McCrae K; Milentijevic D; Germain G; Laliberté F; MacKnight SD; Lefebvre P; Lyman GH; Streiff MB
Cancer Med; 2020 Nov; 9(21):8062-8073. PubMed ID: 32954653
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Khorana Score for Prediction of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
Iqbal U; Elsayed AS; Ozair S; Jing Z; James G; Li Q; Hussein AA; Guru KA
J Endourol; 2021 Jun; 35(6):821-827. PubMed ID: 33218263
[No Abstract] [Full Text] [Related]
8. Healthcare costs of patients with cancer stratified by Khorana score risk levels.
Khorana AA; Kuderer NM; McCrae K; Milentijevic D; Germain G; Laliberté F; MacKnight SD; Lefebvre P; Lyman GH; Streiff MB
J Med Econ; 2021; 24(1):866-873. PubMed ID: 34181497
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
10. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
[TBL] [Abstract][Full Text] [Related]
11. The association between two genetic polymorphisms in
Alsulaim AY; Azam F; Sebastian T; Mahdi Hassan F; AbdulAzeez S; Borgio JF; Alzahrani FM
Saudi J Biol Sci; 2022 Jan; 29(1):183-189. PubMed ID: 35002407
[TBL] [Abstract][Full Text] [Related]
12. Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence.
Tavares V; Neto BV; Vilas-Boas MI; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188778. PubMed ID: 35963552
[TBL] [Abstract][Full Text] [Related]
13. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
15. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
16. [Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].
Zhang XL; Zhu J; Chen WH; Zhai ZG; Zhang YH
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):901-906. PubMed ID: 29665662
[No Abstract] [Full Text] [Related]
17. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.
Beckers MM; Ruven HJ; Haas FJ; Doevendans PA; ten Cate H; Prins MH; Biesma DH
Eur J Intern Med; 2010 Aug; 21(4):289-92. PubMed ID: 20603037
[TBL] [Abstract][Full Text] [Related]
18. Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool.
Patell R; Rybicki L; McCrae KR; Khorana AA
Am J Hematol; 2017 Jun; 92(6):501-507. PubMed ID: 28240823
[TBL] [Abstract][Full Text] [Related]
19. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
Tsubata Y; Kawakado K; Hamai K; Furuya N; Yokoyama T; Saito R; Nakamura A; Masuda T; Hamaguchi M; Kuyama S; Honda R; Senoo T; Nakanishi M; Hotta T; Yamasaki M; Ishikawa N; Fujitaka K; Kubota T; Kobayashi K; Isobe T
Int J Clin Oncol; 2023 Jan; 28(1):69-78. PubMed ID: 36357710
[TBL] [Abstract][Full Text] [Related]
20. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]